NOD2 and graft versus host disease: It was originally postulated that the NOD2 variants that are purported to increase the risk and severity of Crohn's disease might also contribute to the risk of GvHD, particularly gastrointestinal GvHD, due to their notable similarity in clinical symptoms [76].